{"id":"W4408676261","doi":"10.4236/abb.2025.163005","title":"Antiviral Activity of Natural Compounds Immuno Formula Shiban2/5 against SARS-CoV-2","year":2025,"lang":"en","type":"article","venue":"Advances in Bioscience and Biotechnology","topic":"Pharmacological Effects of Natural Compounds","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Natural (archaeology); Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Pharmacology; Chemistry; Biology; Medicine; Infectious disease (medical specialty); Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006230469,0.0002750265,0.0004850494,0.0005247149,0.0002312022,0.00001683007,0.000778467,0.0006417181,0.000004157824],"category_scores_gemma":[0.0002285174,0.0002239861,0.00008056877,0.001417393,0.002453357,0.0005989152,0.0004905764,0.001422607,0.000004540978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009459228,"about_ca_system_score_gemma":0.0000647092,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001660969,"about_ca_topic_score_gemma":0.00007729646,"domain_scores_codex":[0.9981208,0.0002127366,0.0003667189,0.000555519,0.0001375062,0.000606725],"domain_scores_gemma":[0.9989458,0.0005441008,0.0001867117,0.0002324419,0.00005671728,0.00003418255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003112661,0.0002029305,0.003392729,0.00005592698,0.00001808347,0.00001833937,0.00001687156,0.000007182107,0.8353872,0.004696243,0.0001187877,0.1557745],"study_design_scores_gemma":[0.001301788,0.000268301,0.004483638,0.00004582938,0.00002044172,0.00001004446,0.00003265806,0.003408653,0.9523427,0.003302001,0.03454288,0.0002410607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9842736,0.007863084,0.00008982091,0.002778155,0.0014184,0.0003722571,0.0000169618,0.0001326064,0.003055119],"genre_scores_gemma":[0.9919822,0.005307757,0.0004103945,0.00219203,0.00001927418,0.00001953033,0.000003642843,0.000005890157,0.00005926911],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1555334,"threshold_uncertainty_score":0.9133888,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0423942188826499,"score_gpt":0.4357494358528591,"score_spread":0.3933552169702093,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}